Successful use of second cord blood transplantation to achieve long-term remission in cord blood donor cell-derived AML harboring a FLT3-ITD and an NPM1 mutation

Bone Marrow Transplant. 2012 Sep;47(9):1252-3. doi: 10.1038/bmt.2011.256. Epub 2012 Jan 9.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Base Sequence
  • Blood Donors
  • Cord Blood Stem Cell Transplantation / adverse effects
  • Cord Blood Stem Cell Transplantation / methods*
  • Female
  • Humans
  • Leukemia, Myeloid, Acute / etiology
  • Leukemia, Myeloid, Acute / genetics
  • Leukemia, Myeloid, Acute / surgery*
  • Molecular Sequence Data
  • Neoplasms, Second Primary / etiology
  • Neoplasms, Second Primary / genetics
  • Neoplasms, Second Primary / surgery
  • Nuclear Proteins / genetics*
  • Nucleophosmin
  • fms-Like Tyrosine Kinase 3 / genetics*

Substances

  • NPM1 protein, human
  • Nuclear Proteins
  • Nucleophosmin
  • FLT3 protein, human
  • fms-Like Tyrosine Kinase 3